NSE filing, NSE: MARSONS. Summary written from the filing by ALFA Finder's alert engine.
Marsons Ltd: key numbers
- Share price
- ₹153.40
- Market cap
- ₹2,640 Cr
- Revenue (annual)
- ₹245.4 Cr
- Net profit (annual)
- ₹46.33 Cr
- P/E (TTM)
- 59.7×Sector 51.9×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 1.06%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marsons Ltd
All →Marsons Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026, disclosing promoter and public shareholding details.
Marsons Merger & Restructuring
Marsons Ltd approved a JV with Cleanhill Partners to form a US LLC for transformer import and manufacturing. CEO authorized to execute the agreement.
Marsons Capital Structure Change
Anupriya Consultants Pvt. Ltd. (Non-promoter) sold 8,00,000 shares of Marsons Ltd. in the open market. This divestment reduced their stake from 5.81% to 5.35%.
- Execution
- September 28, 2026 to September 29, 2026
Marsons Annual General Meeting
Marsons Limited held its 49th Annual General Meeting on September 30, 2026. Members transacted business including adoption of audited financial statements and director re-appointment.
Marsons Management Change
Marsons Ltd appointed Mr. Rajiv Gupta as Additional Independent Director effective 16 September 2026. The five-year term is subject to shareholder approval.
Marsons Capital Structure Change
Marsons Ltd discloses non-promoter Anupriya Consultants sold 19,28,421 equity shares in the open market. Its stake fell from 6.93% to 5.81% in late Aug-Sep 2026.
Other price movement clarification announcements
All →Aegis Logistics Price Movement Clarification
Aegis Logistics clarified to BSE that the unusual volume surge is purely market-driven with no undisclosed information. The company confirmed compliance with Reg 30 LODR.
Dr. Reddy's Laboratories Price Movement Clarification
Dr. Reddy's confirms FDA tentative approval for its lenacapavir HIV shot. The company states the news is not material and has no material impact.
Yaap Digital Price Movement Clarification
Yaap Digital told NSE no undisclosed event explains its recent share price movement. The Company confirmed all disclosures are timely and the movement is market-driven.
Quality RO Industries Price Movement Clarification
Quality RO Industries clarified BSE's surveillance query on share price movement, stating it was purely market-driven with no undisclosed material information.
Mahanagar Telephone Nigam Price Movement Clarification
MTNL responded to an NSE surveillance query on a volume spurt, stating no undisclosed material information exists. The share price movement is attributed to market conditions alone.
CIAN Agro Industries & Infrastructure Price Movement Clarification
CIAN Agro clarified to BSE that its recent significant share price movement is driven by market conditions. Management says it has no knowledge of the reasons and will keep complying with Regulation 30.